FDA Issues Temporary Policy for Certain Requirements under the Accredited Third-Party Certification Program During COVID-19 Public Health Emergency April 22, 2020 The U.S. Food and Drug Administration (FDA) is issuing a guidance to communicate its temporary policy...
Some industries may deal with frequent bankruptcy problems although all creditors in any industry face the risk of needing to engage in credit collection efforts. Some more frequently indebted businesses, such as retailers or manufacturers, which fail to meet targets...
As we wrote in our previous blog, arbitration is becoming the preferred method many contracting parties use when settling disputes. It’s fair to say that the majority of contractors written between commercial parties and businesses dealing directly with the general...
The National Labor Relations Board is set up to negotiate and decide on disputes that can occur between employees or employers, using state and federal labor laws to render a decision. They deal with issues that affect not only government workers, but also many...
Court litigation is set up as an adversarial process, which requires both sides to pursue their case as aggressively as possible, with the hope that a decision will be made by a Judge in their favor. Notice we use the term "a decision" but not necessarily “justice.”...
All companies have financial obligations and objectives. If these goals are not met, then the door is open to creditors and even shareholders filing legal claims against the company to recoup any avoidable losses suffered. Company structure and operating capital...
It's a fair question: Is the National Labor Relations Board (NLRB) created in 1935 still relevant . In the years immediately following World War II, American industry continued to hum along, fueled by returning GIs starting new families in new residential areas called...
The U.S. Food and Drug Administration has issued a guidance, “Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act.” Due to the COVID-19 pandemic, FDA has been closely monitoring the medical product supply...